News GSK plc

Equities

Real-time Estimate Cboe Europe Other stock markets 03:09:46 2024-04-16 am EDT			5-day change	1st Jan Change
1,618 ^GBX	-1.58%		+1.45%	+13.33%

Apr. 09	Pfizer RSV shot meets goals in trial of high-risk adults under age 60	RE
Apr. 08	GSK : Barclays sticks Neutral	ZD

Pfizer RSV shot meets goals in trial of high-risk adults under age 60	Apr. 09	RE
GSK : Barclays sticks Neutral	Apr. 08	ZD
Barclays Lifts GSK PT, Maintains Equalweight Rating	Apr. 08	MT
Wizz Air raised; HSBC cuts Rentokil to 'hold'	Apr. 08	AN
CureVac Says Phase 2 Interim Data Show Multivalent Flu Vaccine Candidate Boosts Antibody Titers	Apr. 04	MT
GSK : Barclays reiterates its Neutral rating	Apr. 04	ZD
CureVac, GSK's Seasonal Flu Shot Shows Efficacy in Phase 1/2 Study	Apr. 04	MT
CureVac, GSK's Seasonal Flu Shot Shows Efficacy in Phase 1/2 Study	Apr. 04	MT
Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs	Apr. 03	RE
GSK : Berenberg gives a Buy rating	Apr. 03	ZD
GSK : Sell rating from JP Morgan	Mar. 28	ZD
U.S. FDA approves Akebia's anemia drug	Mar. 27	RE
WuXi Biologics Reports Solid 2023 Annual Results	Mar. 27	AQ
GSK FILES FOR DEBT SHELF; SIZE NOT DISCLOSED - SEC FILING…	Mar. 25	RE
Moderna, Inc. prepares for the post-Covid era	Mar. 25
GSK : Director/Pdmr Shareholding - Form 6-K	Mar. 22	PU
British Drugmaker GSK to Introduce Price Cap on Inhaled Products from 2025	Mar. 21	MT
GSK to cap out-of-pocket inhaler costs in US	Mar. 20	RE
GSK Announces Cap Of $35 Per Month On U.S. Patient Out-Of-Pocket Costs	Mar. 20	RE
GSK - PROGRAM IS WIDE REACHING AND WILL BE IMPLEMENTED NO LATER…	Mar. 20	RE

No results for this search

GSK PLC : 2023 ended on a strong note; medium- to long-term guidance raised

February 02, 2024 at 09:40 am EST